Conformis, Inc. to Release Fourth Quarter and Fiscal Year 2021 Financial Results on March 2, 2022
The webcast will be live at: https://edge.media-server.com/mmc/p/6vqkixan
To attend by telephone, please use the information below for dial-in access.
- When prompted on dial-in, please utilize conference ID: 3493739
- Participant conference numbers: (877) 809-6331 (
U.S./ Canada) and (615) 247-0224 (International).
- Please dial in at least 10 minutes before the call to ensure timely participation.
Please visit the Investor Relations website at ir.conformis.com on
The online archive of the webcast will be available on the company’s website at ir.conformis.com for 30 days.
Conformis is a medical technology company focused on advancing orthopedic patient care and creating a world without joint pain. Its product portfolio is designed to maximize surgeon and patient choice by offering fully personalized solutions through its Image-to-Implant® Platinum Services℠ Program as well as data-informed, standardized solutions that combine many benefits of personalization with the convenience and flexibility of an off-the-shelf system. Conformis’ sterile, just-in-time, Surgery-in-a-Box™ delivery system is available with all of its implants and personalized, single-use instruments. Conformis owns or exclusively in-licenses issued patents and pending patent applications that cover personalized implants and patient-specific instrumentation for all major joints.
Source: Conformis, Inc.